Immunomodulation of enteric neural function in irritable bowel syndrome

Area of Science:

• Gastroenterology
• Neurogastroenterology
• Immunology

Background:

• Irritable bowel syndrome (IBS) is a prevalent functional gastrointestinal disorder characterized by visceral pain, bloating, and altered bowel habits.
• The etiology of IBS is complex and multifactorial, with brain-gut axis dysfunction implicated in its pathophysiology.
• Psychosocial and infection-related stressors are linked to IBS symptom onset and exacerbation, with prior gastrointestinal infection being a strong predictor.

Discussion:

• Immune system dysregulation, including mucosal immune cell infiltration and elevated pro-inflammatory cytokines, contributes to IBS.
• These immune mediators directly influence neural signaling within the gut.
• The gut microbiota's role in modulating neuro-immune signaling is an emerging area of research impacting gastrointestinal function and central neural activity.

Key Insights:

• Subtle immune changes and pro-inflammatory cytokines are consistently found in IBS patients.
• The gut microbiota influences neuro-immune pathways, affecting both local GI function and central nervous system processing.
• Understanding these complex neuro-immune and neuroendocrine interactions is crucial for unraveling IBS pathogenesis.

Outlook:

• Further research into the gut microbiota's role in IBS pathophysiology may reveal novel therapeutic targets.
• Investigating the interplay between the gut microbiota, immune system, and brain-gut axis is essential for advancing IBS treatment.
• Developing biomarkers for IBS based on immune and microbial profiles could improve diagnosis and management.